Mirae Asset Global Etfs Holdings Ltd. Vaxcyte, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $41.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 65,311 shares of PCVX stock, worth $6.14 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
65,311
Previous 57,256
14.07%
Holding current value
$6.14 Million
Previous $4.32 Million
72.47%
% of portfolio
0.02%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding PCVX
# of Institutions
354Shares Held
122MCall Options Held
775KPut Options Held
433K-
Vanguard Group Inc Valley Forge, PA11.4MShares$1.08 Billion0.02% of portfolio
-
Janus Henderson Group PLC London, X010.9MShares$1.03 Billion0.67% of portfolio
-
Black Rock Inc. New York, NY9.94MShares$934 Million0.02% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.69MShares$817 Million13.83% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.9MShares$460 Million0.12% of portfolio
About Vaxcyte, Inc.
- Ticker PCVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,315,100
- Market Cap $5.57B
- Description
- Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...